GlassScriptPhysician profile
Wael Adib Jaber
NPI 1437244910
$124,138.13
in general payments reported to CMS, 2019-2025
11 companies · $53K in 2025
The $53K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $20.47 · 2021: $2,624 · 2022: $7,322 · 2023: $20K · 2024: $41K · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $84K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Travel and Lodging: $11K · Food and Beverage: $4,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $84,031.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,962.50 |
| Travel and Lodging | $10,624.07 |
| Food and Beverage | $4,253.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $86,625.82 | 2019-2025 | Watchman Flx, Watchman Access System, Farapulse |
| Pfizer INC. | $36,187.94 | 2021-2025 | |
| Cleerly, INC. | $1,000.00 | 2025 | |
| Biosense Webster, INC. | $150.18 | 2025 | Carto 3 |
| Life Molecular Imaging LTD | $90.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $40.93 | 2025 | Wainua |
| Bayer Healthcare Pharmaceuticals INC. | $22.79 | 2022 | |
| Siemens Medical Solutions USA, INC. | $20.47 | 2020 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wael Jaber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.